Cat Allergy Shot Cost: What Humans Pay Per Visit for Cat SCIT

This page covers allergy shots (subcutaneous immunotherapy, or SCIT) given to HUMANS who are allergic to cats — meaning your immune system produces IgE antibodies against cat proteins such as Fel d 1. This is entirely different from any veterinary immunotherapy, oclacitinib-class drugs, or CYTOPOINT-analog products prescribed by veterinarians to treat feline atopic dermatitis. Those are veterinary products billed to pet insurance or paid as a pet expense. If you have arrived here looking for treatment for your cat's allergies, you are in the wrong place. This page covers human allergy to cats, including costs, insurance coverage, and the per-visit dollar breakdown across every major US payer scenario.

Cat-hair and cat-pelt extracts are the ONLY mammalian allergens with FDA standardization in the United States — both approved at 10,000 BAU/mL under Greer license #308. FDA standardization means each manufactured lot delivers a verified and consistent allergen load per milliliter. Dog extracts, by contrast, are PNU-based (protein nitrogen units) or weight-per-volume formulations sold by Greer, ALK-Abelló, and Hollister-Stier with significant lot-to-lot variability and no FDA standardization. The 2025 Medicare allowed amount for CPT 95165 is identical for both species at $13.91/dose (FR Doc 2024-25382), but the clinical predictability — and therefore the likelihood that you will progress through build-up on schedule without extra visits — is structurally higher for FDA-standardized cat extracts. Same price per CPT, more consistent biology.

A single maintenance cat allergy shot (CPT 95117) at a freestanding allergist office costs $40–$200 billed, with cash retail averages of $85–$100 in most US states per Fair Health and Sidecar Health benchmarks. The Medicare 2025 allowed amount is $11.97 (CY 2025 PFS, FR Doc 2024-25382); commercial payers allow $15.10–$18.05 depending on carrier (PayerPrice, April 2026). If vial preparation (CPT 95165) is performed the same day — typically every 6–12 months — the allowed amount adds $139.10 for a 10-dose vial at Medicare rates, or $260–$420 at commercial rates. At a hospital outpatient department, those same line items can multiply 4–40×: the documented HOPD worst case for a single allergy-testing panel is $24,400 at M Health Fairview Minneapolis, 2024 (PBS NewsHour Weekend). Always ask whether the clinic is provider-based before scheduling.

No. The hypoallergenic cat breed claim is not supported by peer-reviewed evidence and should not be used to plan SCIT cost avoidance. Hairless Sphynx cats — widely marketed as hypoallergenic — still produce Fel d 1 at meaningful levels, as confirmed by Hilger et al. (PMC10975736, 2024). Fel d 1 is a secretoglobin produced primarily in skin sebaceous glands and salivary glands, not in fur. Removing hair does not eliminate the primary allergen source. Similarly, Siberian cat hypoallergenic claims lack rigorous peer-reviewed validation. Bastien et al. (J Feline Med Surg 2019) documented 80-fold variation in salivary Fel d 1 between individual domestic shorthair cats — individual cat variation is real, but breed selection is not a reliable or peer-reviewed strategy for reducing Fel d 1 exposure or eliminating the need for SCIT.

Yes. Medicare Part B covers subcutaneous allergen immunotherapy (SCIT) for medically necessary allergic conditions including cat sensitization. The 2025 Medicare Part B deductible is $257 ($283 in 2026, per CMS announcement November 14, 2025). After the deductible is met, Medicare pays 80% of the allowed amount and the patient owes 20% coinsurance — approximately $2.39 per maintenance visit for CPT 95117 alone, or roughly $31.76 when a 10-dose vial preparation (CPT 95165 × 10) is included on the same day. A Medigap supplemental policy eliminates the 20% coinsurance entirely, making cat SCIT $0 per visit on an ongoing basis. Medicare does not cover sublingual immunotherapy drops. There are no network restrictions under Original Medicare, though clinical necessity must be documented per CMS LCD L36240.

A hospital outpatient department (HOPD) bills two separate charges for the same allergy visit: a professional fee under the Medicare Physician Fee Schedule and a facility fee under the hospital Outpatient Prospective Payment System. The facility fee is not bounded by the contracted professional rate and can multiply the total bill dramatically. The clearest documented example: Kaitlin Johnson's 40-allergen skin-test panel at M Health Fairview in Minneapolis (an HOPD) was billed $24,400 in 2024 — while nearby freestanding clinics quoted $800–$1,827 for the identical panel (PBS NewsHour Weekend, 2024). Before scheduling any allergy appointment, ask the billing department: 'Is this practice classified as a provider-based facility or a hospital outpatient department?' and request the expected facility fee amount in writing before your first visit.

Fel d 1 is a 35–38 kDa tetrameric secretoglobin — the major cat allergen — produced in sebaceous and salivary glands. Fel d 1 sensitizes 90–96% of cat-allergic patients (Satyaraj et al., Allergy 2019; Grönlund et al., Int Arch Allergy Immunol 2010). Because Fel d 1 dominates IgE responses in cat-allergic adults, a single FDA-standardized cat extract vial is typically sufficient for SCIT. Intact male cats produce 3–5× more Fel d 1 than neutered males (Kelly et al., JACI 2018: median urinary Fel d 1 5.15 μg/mL intact vs 0.013 neutered, P=0.012). A patient whose primary exposure is an intact male cat may experience symptom reduction after neutering, which can affect the SCIT cost-benefit calculation before committing to a 3–5 year protocol.